Efficacy and Safety of Eslicarbazepine Acetate as Preventive Therapy for Subjects With Migraine

NCT01820559 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

452

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Placebo
DRUG: ESL 1200 mg
DRUG: ESL 800 mg

Sponsor

Bial - Portela C S.A.